On that note, demand for the newest Kangaroo OMNI Enteral Feeding Pump has continued to build ... And that concept was recently tested yet again with insulin and those dramatic price reductions ...

There has been a lot of debate recently around pharma and its pursuit of multi-channel or omni-channel marketing ... more than standard monitors and insulin pumps did when tested for five days ...

Despite winning an FDA green light nearly three months ago for its first wearable insulin delivery system, Embecta is now ...

CEO Dev Kurdikar said the decision may “come as a surprise” as Embecta just received FDA clearance for a patch pump, but the company “did not intend to do a full market launch of this product.” ...

Embecta announced today that it discontinued its insulin patch pump program and plans to initiate a restructuring plan.

Kurdikar, CEO of Embecta (EMBC) said, “As our stand-up work nears completion and following an in-depth review of our portfolio ...

The InPen app paves the way for the launch of the company’s “Smart MDI” system combining a smart insulin pen that tracks ...

The clearance allows the system to offer personalised insights for individuals managing diabetes through MDI therapies.

The clearance paves the way for the launch of Medtronic’s Smart MDI system, which combines its InPen and Simplera continuous ...

Nov 7(Reuters) - Insulet (PODD.O), opens new tab raised its annual revenue growth forecast on Thursday, banking on strong demand for its wearable insulin pumps. Shares of the medical device maker ...

They're finally here with the Omni One, though the device has its own pros and cons. The Omni One is a full-body VR rig that includes a headset, controllers, body support vest and a disc-like ...